New medicines on the market ZURICH – Roche said strong sales of new medicines like cancer immunotherapy drug Tecentriq would help to sustain the company’s growth as patents on older drugs start to expire. Chief executive Severin Schwan is betting he can stay ahead of the sales erosion with new medicines that include five launched […]

Continue reading this article with a Fiji Times online membership.

More Stories